Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]NGM Biopharmaceuticals"
Count: 24
Selected: 0
| NCT ID | Title |
|---|
| NCT02443116 | Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH) | ||
| NCT02135536 | Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis | ||
| NCT02026401 | Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis | ||
| NCT01943045 | Phase 2 Study of NGM282 in Patients With Type 2 Diabetes | ||
| NCT04465955 | A Study of NGM621 in Participants With Geographic Atrophy | ||
| NCT04210245 | Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) | ||
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | ||
| NCT05215574 | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | ||
| NCT04913337 | Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | ||
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | ||
| NCT04582318 | A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 | ||
| NCT04828265 | Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects | ||
| NCT04823702 | Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function | ||
| NCT03912532 | Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) | ||
| NCT04187339 | Study of NGM395 in Adult Participants | ||
| NCT04014777 | Study of NGM621 in Participants With Geographic Atrophy | ||
| NCT04179630 | Study of Aldafermin (NGM282) in Participants With Impaired Renal Function | ||
| NCT03392116 | Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects | ||
| NCT03298464 | Study of NGM313 in Obese Participants | ||
| NCT02704364 | Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis | ||
| NCT02649062 | Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals | ||
| NCT02708576 | Phase 1 Study of NGM313 in Healthy Adult Participants | ||
| NCT01776528 | Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants | ||
| NCT05130047 | Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) |
